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COMBINED EFFECT OF BOTULINUM TOXIN TYPE A
INJECTION AND INTENSIVE OCCUPATIONAL
THERAPY IN TREATMENT OF SPASTIC PRONATORS
IN CHILDREN WITH CEREBRAL PALSY
Sanne S.L. Fong1, Kwok Bun Tam2, Catherine K.Y. Fung1, Vivian W.Y. Chui1, 
Stella W.C. Cheng1, Grace S.F. Ng3, Teresa Y.L. Wong3 and Kwok Yin Chan3
Objective: Botulinum toxin type A (BtA) injection in the therapeutic treatment of muscle hypertonicity
has been documented to reduce spasticity in specific muscle groups, with the effect lasting 1–3 months.
The objective of this study was to evaluate the combined effect of an intensive occupational therapy (OT)
programme following BtA injection in the treatment of spastic pronators in children with cerebral palsy.
Methods: This study used a pre/post intervention measurement design. Five children with cerebral palsy
and hand function impairment were enrolled for intervention and followed-up longitudinally at 1, 3, 6
and 12 months. All patients received BtA injection to left pronators followed by OT according to treatment
guidelines and standard assessment protocol. Outcome measures included change in spasticity, active range
of motion (AROM), sensibility, power grip strength and functional hand grips.
Results: Significant improvements in muscle tone, AROM, sensibility and functional hand grips were
observed over time. The restoration of hand function and sensibility lasted up to 12 months after injection.
In addition, we observed that four children gained sensibility, which did not demonstrate any tendency to
diminish with time.
Conclusion: A combination of BtA injection and OT is effective for reducing spasticity in the pronators
of children with cerebral palsy.
KEY WORDS: Botulinum toxin injection • Cerebral palsy • Occupational therapy • Spastic pronators
Introduction
Children with cerebral palsy (CP) usually present with typical
deformities that include elbow flexion, forearm pronation, thumb
adduction in palm, wrist flexion and ulnar deviation, which limit
the normal exploration of their environment. In children with
CP, the spasticity due to upper motor neuron lesion can interfere
with mobility, self-care, positioning, and will sometimes lead
to deformities. Ruthman (1986) compared CP children with their
normal counterparts with regard to the influence of impaired
mobility on acquisition of one aspect of cognition development;
the results suggested that ordering movements might be limited
in children with CP as a result of their limited motor experi-
ence, particularly at a young age. On the other hand, Cooper,
Majnemer, Rosenblatt, and Birnbaum (1995) reported that
30–97% of patients with CP have defective stereognosis. Any
intervention that will allow more efficient use of the spastic
hand should therefore lead to an improvement in stereognosis.
Dahlin, Salgeback, Komoto-Tufvesson, and Lundborg (1998)
suggested that the brain areas for reception of afferent impulses
may be downregulated as a result of non-use of the hands, but
stereognosis can be improved following surgical reconstruction
of the upper extremity in patients with CP due to functional
cerebral reorganization induced by the modified afferent inflow.
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They studied 36 patients with hemiplegic CP who were treated
with various surgical means of tendon transfer to improve or
correct their supination, wrist extension or the thumb-in-palm
deformity, which was then followed by comprehensive hospital-
based occupational therapy (OT). They observed improvements
in stereognosis.
Botulinum toxin type A (BtA) injection has been used 
in the treatment of hemiplegic upper limb muscle hypertonic-
ity in children with CP. Local intramuscular injection of BtA
assisted in reducing disability and enhanced functional im-
provements, having a high impact on the activities of daily liv-
ing and on quality of life (Mall, Heinen, Linder, Philipsen, &
Korinthenberg, 1997). Intramuscular injection of BtA is believed
to be a safe and effective measure for relieving spasticity in
paediatric CP patients, to diminish painful spasticity, to facili-
tate positioning and hygiene, to improve ambulation and upper
limb function, and to be a useful diagnostic aid in determining
the efficacy of surgery. Suputtitada (2000) indicated that a
very low dose of BtA combined with rehabilitation therapy
resulted in a long-lasting decrease in spasticity and an im-
provement in gait in children with CP. There is much in the lit-
erature on the basic principles of the mode of action, side
effects, therapy failure, and potency comparison of BtA and
its clinical applications to dystonia and spastic conditions in
children with CP (Borodic, Ferrante, Pearce, & Smith, 1994;
Lagalla, Danni, Reiter, Ceravolo, & Provinciali, 2000; Lee &
Powell, 1990; Yasukawa, 1990). However, it has been gener-
ally reported that the effects last for only about 3 months
(Corry, Cosgrove, Walsh, McClean, & Graham, 1997; Graham,
2000).
Eliasson (1995) wrote that functional hand movements in
daily life are built up by motor sequences related to sensory,
perceptual, and cognitive functions. Most children with CP have
no functional sensorimotor integration during the grasping task
as their force generation is usually unstable, which will affect
their handling of objects. Moreover, their anticipatory control
is poor and they cannot rely on stable force generation or effi-
cient sensory feedback to generate an effective force. By alter-
ing the muscle tone with BtA injection, function can be enhanced
or additional therapeutic modalities can be employed. Hence,
BtA injection followed by an intensive rehabilitation pro-
gramme with repetition of goal-directed activities can lead
children with CP to experience a process of progressive adjust-
ment and master a skilled movement (Russman, Tilton, &
Gormley, 1997).
An OT rehabilitation programme will usually include splint-
ing as a type of environmental intervention. Static splints that
can provide maximum extension and/or abduction stretch
beyond the point of spasticity can prevent deformity and con-
tracture resulting from spasticity (Spencer, 1983). Preston
(2004) suggested that the use of serial casting and static splints
(6–8 hours/day) can maintain range of motion. In this study,
we hypothesized that serial splinting as a home programme in
addition to intensive functional training conducted by occupa-
tional therapists in adjunct with BtA injection therapy can
optimize the effect of BtA treatment in the reduction of spas-
ticity and improvement of hand function in children with CP.
Specifically, the objective of this study was to investigate the
effectiveness of a combination of BtA injection and OT pro-
gramme for children with CP in the acquisition of hand grasp
control.
Methods
This study used a pre/post intervention measurement design
with longitudinal follow-ups at 1 month, 3 months, 6 months
and 12 months. Five patients were recruited from a bimonthly,
multidisciplinary Paediatric Hand Clinic in an acute hospital
between August 2002 and July 2005. The demographic char-
acteristics of the patients are shown in the Table. The clinic is
jointly run by an orthopaedic surgeon, paediatric neurologists
and occupational therapists. The inclusion criteria for the
patients to be enrolled in the study were: (1) presence of spas-
tic pronators with good rehabilitation potential; (2) reasonable
intelligence; (3) supportive family; (4) strong motivation to
use the affected hand; (5) willingness to follow intensive treat-
ment and assessment programme; and (6) good compliance
with the splinting programme. All patients were followed-up
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Table. Patients’ demographic characteristics
Patient Gender Diagnosis Age (yr) BW (kg) Muscle injected
1 Male Triplegia Lt > Rt 10.5 35 Lt PQ; Lt PT
2 Female Triplegia Lt > Rt 8.5 18 Lt PT; Lt Br; Lt FCU
3 Female Lt hemiplegia 4 12.8 Lt PT
4 Female Lt hemiplegia 5 19.6 Lt PT
5 Female Rt hemiplegia 7 20.8 Rt PT
BW = body weight; Lt = left; Rt = right; PQ = pronator quadratus; PT = pronator teres; Br = brachialis; FCU = flexor carpi ularis.
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longitudinally for up to 12 months and all had received BtA
injection to the left pronator teres and/or pronator quadratus.
A standard assessment protocol and treatment guidelines were
established to ensure that the patients would benefit from
optimal rehabilitation after BtA injection.
Botulinum Toxin Type A (BtA) Injection
BtA (DYSPORT, Ipsen Pharmaceuticals, France) was recon-
stituted for injection using 200–500 U for large muscles, and
100–300 U for small muscles. The dosage was calculated with
reference to recommendations from the literature and the man-
ufacturer according to the body weight of the patients, with the
maximum dose being 20–25 U/kg body weight. The pronator
teres or pronator quadratus was identified by an experienced
orthopaedic surgeon, and all injections were given by the same
surgeon. Injection was delivered with a 2.5-mL syringe using
a 25-gauge needle to reduce pain and to minimize muscle
trauma and bleeding. During injection, each patient was asked
to sit and rest their forearm on the table or to lie supine on the
bed to make sure that he/she could adopt a comfortable and
relaxed position.
Occupational Therapy (OT) Programme
After injection, all patients were put on an OT programme.
Treatment by occupational therapists included prescription of
a forearm supination splint and intensive training for hand
grasp and release and dexterity, as well as a strengthening and
sensory reeducation programme. Standardized OT treatment
guidelines were established to ensure that the patients would
benefit from optimal rehabilitation after BtA injection. Within
1 week after injection, an occupational therapist would fabri-
cate a forearm supination splint with thermoplastic material at
60–70°C to keep the forearm in maximal supination (Figure 1).
All patients needed to wear the splint for 8–12 hours per day
when asleep. The programme also included a weekly training
session with remedial activities to develop hand function and
sensibility, and to strengthen power grip and pinch grip (Appen-
dix). The intensive training lasted for 2 months, after which the
number of training sessions was reduced to once every 2 weeks
(same as before the patients received the BtA injection).
Assessment
Assessments included: (1) active range of motion (AROM) as
measured by a goniometer; (2) spasticity as measured by the
Modified Ashworth Scale (Bohannon & Smith, 1987); (3)
functional hand grips (Eliasson, Ekholm, & Carlstedt, 1998);
(4) grasp and release of a film capsule (Corry et al., 1997); (5)
sensibility as represented by stereognosis performance; (6)
quality of hand function as measured by the Jebsen-Taylor
Hand Function Test (Jebsen, Taylor, Trieschmann, Trotter, &
Howard, 1969); and (7) power grip strength as measured by a
dynamometer. For functional hand grips, there were nine items
studying transverse grasp, diagonal grasp, five-finger pinch,
tripod pinch, lateral pinch, and tip to tip pinch with grading
from 0 to 4 for each grip according to how well the child per-
formed. Based on a total score of 36, children were ranked
according to their individual score, ranging from severe im-
pairment (≤ 13), to moderate impairment (14–21), to mild
impairment (≥ 22) (Eliasson et al.). All patients were evalu-
ated at baseline (pre-injection), and then post-injection at 1, 3,
6 and 12 months. In order to avoid assessment bias, all patient
assessments were done and documented by the same occupa-
tional therapist, with video and photographic recording for
subsequent review and analysis by another occupational ther-
apist who confirmed the assessment results.
Results
Active Range of Motion (AROM)
There was an increase in active supination (Figure 2) and wrist
extension (Figure 3) of the hands at 1, 6 and 12 months after
injection. There was an average increase of 60° in supination.
However, there was not much change in active pronation range
and elbow range (Figures 4 & 5).
Change in Spasticity
In the first month after injection of BtA into the pronator teres
and/or pronator quadratus, the muscle tone of the pronators
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Figure 1. A forearm supination splint.
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was reduced from 1+–3 to 1–2 (Figure 6), and that of the wrist
flexors was reduced from 1–2 to 0–2 (Figure 7), according to
the Modified Ashworth Scale. The effect lasted until 6 months
after injection. The reduction in the degree of abnormal muscle
tone of the pronator teres and pronator quadratus had also
lessened the tension of other muscles. Since the action of the
pronator teres includes pronation of the forearm and flexion of
the elbow, with release of the pronator teres, there was improve-
ment in the muscle tone of the elbow flexors (Figure 8).
Functional Hand Grips
Mean functional hand grip increased gradually from 14.6
(range, 1–22) before injection to 24.4, 26.0, 24.8 and 24.0 at
months 1, 3, 6 and 12 after injection, respectively. It was ob-
served that functional hand grip improved dramatically within
the first month, then gradually slowed down to a plateau or
was reversed by 6 months (Figure 9). However, in general,
overall score was better at 6 months. Among the five patients,
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Figure 3. Change in the active range of motion (AROM) of wrist
extension in the five patients. Pre-inj = pre-injection.
Pre-inj 1 mo 3 mo 6 mo 12 mo
0
20
40
60
80
100
A
RO
M
 (°
)
1 4 52 3
Figure 4. Change in the active range of motion (AROM) of fore-
arm pronation in the five patients. Pre-inj = pre-injection.
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Figure 6. Change in the spasticity of forearm pronators in the
five patients. Pre-inj = pre-injection.
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Figure 7. Change in spasticity of wrist flexors in the five
patients. Pre-inj = pre-injection.
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Figure 2. Change in active range of motion (AROM) of forearm
supination in the five patients. Pre-inj = pre-injection.
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Figure 5. Change in the active range of motion (AROM) of the
elbow in the five patients. Pre-inj = pre-injection.
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Figure 8. Change in spasticity of elbow flexors in the five
patients. Pre-inj = pre-injection.
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two had improved from severe to mild and another two had
improved from moderate to mild, while one patient received
an additional injection 9 months after the first injection.
Grasp and Release
All patients had improvement in the grasp and release pattern
of a film capsule for a mean of 1.3 units of scoring with better
posture. Only one patient needed an additional injection 9
months after the first injection (Figure 10) to enhance the
grasp and release action.
Sensibility
With the improvement in muscle tone and further improve-
ment in dexterity enabling the patients to further explore dif-
ferent objects, an overall improvement in stereognosis was noted.
One year after injection and the rehabilitation programme, four
patients were still maintaining their gained skills in stereognosis
and were able to discriminate 11–14 objects in the stereognosis
kit (Figure 11).
Quality of Hand Function
With improvement in the quality of hand function, patients
could perform more sophisticated hand tasks. The Jebsen-Taylor
Hand Function Test was used to assess the speed of completing
seven hand functional tasks. Most patients showed improvement
in the efficiency of picking up small objects, stacking checkers
and turning cards. However, the changes in tasks that demanded
active supination of the forearm and stabilization of the wrist
such as controlling a spoon during simulated feeding, turning
cards and controlling a pen during writing were not obvious.
None of the patients could pick up large and heavy objects,
which demands a wide span and strong wrist stabilization.
Power Grip Strength
The mean grip strength was 3.0 kgf before injection and was
1.85 kgf, 2.3 kgf, 2.1 kgf and 2.625 kgf in months 1, 3, 6 and
12 after injection, respectively. Grip strength measured before
BtA injection was probably a result of hypertonicity rather
than an actual functional strength. Hence, it was not a surprising
finding that after BtA injection, grip strength was apparently
reduced. It was expected that grip strength dropped in the first
month, and then when abnormal muscle tone returned, apparent
grip strength increased again (Figure 12).
Discussion
After injection of BtA, the spasticity of the pronator teres
and/or pronator quadratus was reduced, and the active range
of wrist extension and supination improved. There was also
relief in the tension of the joint capsule of the wrist joint.
Hence, active participation in rehabilitation was facilitated, and
proprioception and stereognosis were enhanced. This, in turn,
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Figure 9. Change in functional hand grip performance in the
five patients. Pre-inj = pre-injection.
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Figure 10. Change in grasp and release performance of a film
capsule in the five patients. Pre-inj = pre-injection.
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Figure 11. Change in stereognosis in the five patients. Pre-inj =
pre-injection.
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facilitated motor learning for normal movement pattern of
hand functions. All patients developed a more efficient grasp
and release pattern with better posture, such as picking up small
objects and turning cards. Functional hand grip improved and
lasted longer than expected after the effects of BtA subsided.
The reduction in the degree of abnormal muscle tone of
the pronator teres and/or pronator quadratus also lessened the
tension of other muscles, although we could not exclude the
possible diffusion effect of BtA to other muscles upon injec-
tion. With improvements in muscle tone and dexterity, patients
had more opportunity to explore different objects, which led
to an overall improvement in stereognosis. From our observa-
tions, younger patients had better functional reorganization of
the somatosensory cortex of the brain compared to older patients,
and were thus able to learn the sensibility better after BtA
injection, and no deterioration was noted after this gain.
Krumlinde-Sundholm and Eliasson (1993) studied 25 children
with spastic hemiplegia and found that spasticity and defi-
cient sensibility were significantly correlated with dexterity
of the hemiplegic hand. It was believed that there was func-
tional reorganization of the somatosensory cortex of the brain
as a result of changes in afferent input from the hand. In our
study, patients with less severe functional impairment improved
better as the area in the brain for reception of afferent impulses
was not completely downregulated, i.e. less severe impairment
in hand function facilitated functional cerebral reorganization
by modified afferent inflow during sensory education.
The measured grip strength before injection was actually 
a measure of grip strength due to hypertonicity. Therefore,
grip strength was reduced significantly after injection, and the
gradual restoration of grip strength to lower than pre-injection
levels reflected that actual grip strength might be weaker. This
indicated that more strengthening elements to both agonist
and antagonist should be offered in the training programme.
The optimal time for training of muscle strength lay between
1 and 6 months after injection. Before the injected muscle
returned to its hypertonic state, the antagonist could gain a cer-
tain degree of strength so as to retain control of the affected
hand. Duff and Gordon (2003) suggested that practice sessions
should incorporate lifts with novel objects to enhance antici-
patory force scaling and related prehensile function in children
with hemiplegic CP.
In summary, our study produced similar results as that
seen in other countries. Our patients lost muscle strength and
had compromised hand function in the first month, but they
gradually improved in muscle strength, AROM, and hand func-
tions to a maximum by 3 months. This pattern was consistent
with the results of other similar studies. In addition, we also
observed that four out of the five patients gained sensibility,
which had no tendency to diminish with time. 
Furthermore, better results were noted in the younger
patients, those who had disabilities without contracture, rea-
sonable intelligence, and very good family support, as well as
those with specific hand tasks to achieve before injection, and
those who demonstrated good compliance with the rehabili-
tation programme. All these factors contributed to the success
of the BtA injection and these types of patients were expected
to benefit most from our intervention.
Lastly, the patients were able to learn sensibility after BtA
injection. The injection had broken a vicious cycle and enhanced
the development of sensibility and the motor learning process.
Sensory information (Eliasson, 1995; Eliasson et al., 1998) was
important in learning movements; the sensory signals corrected
and adjusted the movements and updated the motor programme
for correct execution the next time the programme was used.
The patient who would benefit most from BtA treatment is the
one who is hypertonic and whose abnormal muscle tone is
interfering with function, or who is expected to develop joint
contracture with growth because of this abnormal tone. By
altering this muscle tone, function can be enhanced or additional
therapeutic modalities can be employed (Russman et al., 1997).
In this study, an intensive OT programme was implemented
after BtA injection. The effect of this combined treatment
lasted for at least 6 months. The provision of intensive training
and patients’ compliance with the splinting programme con-
tributed to postpone the reversal of the effects of BtA injection.
Hence, patients could maintain a prolonged effect and the timing
of optimal functioning was able to be maximized as compared
with other similar studies.
There were limitations in this study. Only five patients were
recruited, which obviously limits the generalizability of the
study results. It was also difficult to recruit patients who were
treated with BtA injection alone without the use of any other
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Figure 12. Change in power grip strength in the five patients.
Pre-inj = pre-injection.
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kind of intervention, so we could not compare the effects of
combined treatment with the effects of BtA injection alone.
Conclusion
BtA injection should not be used alone. Instead, injection of
BtA to the extensors should be followed-up by an intensive
OT programme, with emphasis on the development of sensa-
tion and strengthening of wrist joint muscles. There was evi-
dence that the success of surgery correlated very closely with
good preoperative stereognosis training (Zancolli & Zancolli,
1990). We also recommend a course of intensive sensory reedu-
cation and motor learning to children with CP after any BtA
injection before reconstructive hand surgery is considered.
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ect
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 D
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nsi
en
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 re
v
er
sib
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 e
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ct
.
2) 
If 
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 re
su
lt i
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ati
sfa
ct
or
y,
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 c
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lin
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ul
tip
le
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 m
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 c
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